Adler Institute for Advanced Imaging

ABOUT AIAI

Our Staff

Medical expertise combined with a special focus on patient comfort set Adler apart from other imaging centers.


Dr. Lee P. Adler

Medical Director at Adler and internationally recognized leader in PET and PET/CT


Dr. Karel D. Kovnat

CEO and Director of Neuropsychological Research at AIAI.


Our Facility

Our facility reflects the care and emphasis we put on patient well-being. Take a quick tour.


Hours and Directions

Directions and map, plus hours of operation.


Parking

Parking map and directions.


Adler Firsts

Pioneering achievements.



ACR Accreditation Logo
ABOUT AIAILee P. Adler, MD

1. Peyster RG, Hoover ED, Adler LP. CT of the normal pituitary stalk. AJNR Am J Neuroradiol 1984; 5:45-47.

2. Peyster RG, Adler LP, Viscarello RR, Hoover ED, Skarzynski J. CT of the normal pituitary gland. Neuroradiology 1986; 28:161-165.

3. Peyster RG, Ginsberg F, Silber JH, Adler LP. Exophthalmos caused by excessive fat: CT volumetric analysis and differential diagnosis. AJNR Am J Neuroradiol 1986; 7:35-40.

4. Maurer AH, Milmond SH, Knight LC, Mesgarzadeh M, Shuman CR, Adler LP, Greene GS, Malmud LS. Infection in diabetic osteoarthropathy: use of indium labeled leukocytes for the diagnosis. Radiology 1986; 161:221-225.

5. Schwab FJ, Glick SN, Teplick SK, Adler LP. The barium enema scout film: cost effectiveness and clinical efficacy. Radiology 1986; 160:619-622.

6. Peyster RG, Ginsberg F, Silber JH, Adler LP. Exophthalmos caused by excessive orbital fat: CT volumetric analysis and differential diagnosis. AJR Am J Roentgenol 1986; 146:459-464.

7. Siegel JA, Urbain JL, Adler LP, Charkes ND, Maurer AH, Krevsky B, Knight LC, Fisher RS, Malmud LS. Biphasic nature of gastric emptying. Gut 1988; 29:85-89.

8. Maurer AH, Knight LC, Elfenbein IB, Siegel JA, Adler LP. Paramagnetic pyrophosphate preliminary studies on magnetic resonance contrast enhancement of acute myocardial infarction. Invest Radiol 1990; 25:153-163.

9. Adler LP, Blair HF, Williams RP, Pathria MN, Makley JT, Joyce MJ, al-Kaisi N, Miraldi F. Grading liposarcomas with PET using [18F]FDG. J Comput Assist Tomgr 1990; 14:960-962.

10. Morrison SC, Adler LP. Photopenic areas on bone scanning associated with childhood leukemia. Clin Nucl Med 1991; 16:24-26.

11. Berridge MS, Adler LP, Nelson AD, Cassidy EH, Muzic RF, Bednarczyk EM, Miraldi F. Measurement of human cerebral blood flow with [15O]butanol and positron emission tomography. J Cereb Blood Flow Metab 1991; 11:707-715.

12. Adler LP, Blair HF, Makley JT, Williams RP, Joyce MJ, Leisure G, al-Kaisi N, Miraldi F. Noninvasive grading of musculoskeletal tumors with positron emission tomography. J Nucl Med 1991; 32:1508-1512.

13. Gentili A, Miron SD, Adler LP, Bellon EM. Incidental detection of urinary tract abnormalities with skeletal scintigraphy. Radiographics 1991; 11:571-579.

14. Bednarczyk EM, Green JA, Nelson AD, Leisure GA, Little D, Adler LP, Berridge MS, Panacek EA, Miraldi FD. Comparison of the effect of temafloxacin, ciprofloxacin, or placebo on cerebral blood flow, glucose, and oxygen metabolism in healthy subjects by means of positron emission tomography. Clin Pharmacol Ther 1991; 50:165-171.

15. Adler LP, Blair HF, Makley JT, Pathria MN, Miraldi F. Comparison of PET with CT, MRI, and conventional scintigraphy in a benign and in a malignant soft tissue tumor. Orthopedics 1991; 14:891-895.

16. Paschal CB, Haacke EM, Adler LP, Finelli DA. Magnetic resonance coronary artery imaging. Cardiovasc Intervent Radiol 1992; 15:23-31.

17. Wielopolski PA, Haacke EM, Adler LP. Three-dimensional MR imaging of the pulmonary vasculature: preliminary experience. Radiology 1992; 183:465-472.

18. Morrison SC, Adler LP. Bone imaging agent uptake with hepatoblastoma. Clin Nucl Med 1992; 17:680.

19. Bednarczyk EM, Green JA, Nelson AD, Leisure GP, Little D, Adler LP, Berridge MS, Panacek EA, Miraldi FD. Comparative assessment of the effect of lomefloxacin, ciprofloxacin, and placebo on cerebral blood flow, and glucose and oxygen metabolism in healthy subjects by positron emission tomography. Pharmacotherapy 1992; 12:369-375.

20. Gentili A, Gilkeson RC, Adler LP. Scintigraphic detection of bile leaks after laparoscopic cholecystectomy. Clin Nucl Med 1993; 18:1-6.

21. Gentili A, Adler LP. Detection of inguinal hematoma during a gastrointestinal bleeding study. Clin Nucl Med 1993; 18:254.

22. Wielopolski PA, Haacke EM, Adler LP. Evaluation of the pulmonary vasculature with three dimensional magnetic resonance imaging techniques. MAGMA 1993; 1:21-34.

23. Li D, Paschal CB, Haacke EM, Adler LP. Coronary arteries: three-dimensional MR imaging with fat saturation and magnetization transfer contrast. Radiology 1993; 187:401-406.

24. Paschal CB, Haacke EM, Adler LP. Three-dimensional MR coronary arteries: preliminary clinical experience. J Magn Reson Imaging 1993; 3:491-500.

25. Adler LP, Crowe JP, al-Kaisi NK, Sunshine JL. Evaluation of breast masses and axillary lymph nodes with [F-18] 2-Deoxy-2-fluoro-D-glucose PET. Radiology 1993; 187:743-750.

26. Adler LP, Bloom AD. Positron emission tomography of thyroid masses. Thyroid 1993; 3:195-200.

27. Bloom AD, Adler LP, Shuck JM. Determination of malignancy of thyroid nodules using positron emission tomography. Surgery 1993; 114:728-735.

28. Gentili A, Miron SD, Adler LP. Nuclear medicine atlas: review of some common artifacts in nuclear medicine. Clin Nucl Med 1994; 19:138-143.

29. Crowe JP, Adler LP, Shenk RR, Sunshine J. Positron emission tomography and breast masses: comparison with clinical, mammographic, and pathological findings. Ann Surg Oncol 1994; 1:132-140.

30. Bednarczyk EM, Adler LP, Remler B, Goyer P, Wiznitzer M, Leisure GP, Little D, Miraldi F. Assessment of the effects of ciprofloxacin and nalidixic acid on cerebral blood flow and metabolism in healthy subjects by positron emission tomography. Pharmacotherapy 1994; 14:153-161.

31. Carlson MD, White RD, Trohman RG, Adler LP, Biblo LA, Merkatz KA, Waldo AL. Right ventricular outflow tract ventricular tachycardia: detection of previously unrecognized anatomic abnormalities using cine magnetic resonance imaging. J Am Coll Cardiol 1994; 24:720-727.

32. Lanzieri CF, Tarr RW, Landis D, Selman WR, Lewin JS, Adler LP, Silvers JB. Cost-effectiveness of emergency intraarterial intra-cerebral thrombolysis. Am J Neuroradiol 1995; 16:1987-1993.

33. Adler LP, Faulhaber PF, Schnur KC, Al-Kaisi NL, Shenk RR. Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET. Radiology 1997; 203:323-327.

34. Adler LP, Akhrass R, Ma D, Bloom AD. False-positive parathyroid scan leading to sternotomy: incidental detection of a thymoma by C-11 methionine positron emission tomography. Surgery 1997; 122:116-119.

35. Leisure GP, Vesselle HJ, Faulhaber PF, ODonnell JK, Adler LP, Miraldi F. Technical improvements in fluorine-18-FDG PET imaging of the abdomen and pelvis. J Nucl Med Technol 1997; 25:115-119.

36. Sandoval BA, Goettler CE, Robinson AV, ODonnell JK, Adler LP, Stellato TA. Cholescintigraphy in the diagnosis of bile leak after laparoscopic cholecystectomy. Am Surg 1997; 63:611-616.

37. Miraldi F, Adler LP, Faulhaber P. PET imaging in soft tissue sarcomas. Cancer Treat Res 1997; 91:51-64.

38. Chen CH, Muzic RF Jr, Nelson AD, Adler LP. Bias in PET quantitation due to camera calibration procedures. J Nucl Med 1997; 38:1334-1335.

39. Adler LP, Faulhaber PF, Schnur KC, Al-Kaisi NL, Shenk RR. Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET. Radiology 1997; 203:323-327.

40. Miraldi F, Faulhaber PF, Vesselle HJ, Adler LP, Leisure GP. Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer. Clin Nucl Med 1998; 23:3-7.

41. Chen CH, Muzie RF Jr, Nelson AD, Adler LP. A nonlinear spatially variant object-dependent system model for prediction of partial volume effects and scatter in PET. IEEE Trans Med Imaging 1998; 17:214-227.

42. Adler LP, Bakale G, Schnur KC, Shenk RR. Innovations in breast cancer imaging: PET for diagnosis, and follow-up. Medscape Womens Health 1998; 3:5.

43. Gilkeson RC, Adler LP. Rounded Atelectrasis: Evaluation With 18FDG PET. Clin Positron Imaging 1(8) Fall 1998:229-32.

44. Chen C-H, Muzic RF Jr, Nelson AD, Adler LP. Simultaneous recovery of size and radioactivity concentration of small spheroids with PET Data. J Nucl Med 1999; 40:118-130.

45. Rose PG, Adler LP. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol. 1999, Jan: 17(1):41-5.

46. Parry EJ, Adler LP. Management of cutaneous lymphomas using a multidisciplinary approach. Arch Dermatol. 1999 Aug; 135(8):907-911.

47. Riedy G, Adler LP. Tc99M MDP Thyroid Uptake in a Patient with a large nontoxic goiter. Clin Nucl Med 2000 Nov; 25(11):929-930.

48. Adler LP, Freimanis R, Lesko N, Geisinger K, Levine E, Perrier N, Newman D, Williams R, Bakale G, Zawarzin VV, Weinberg II. Problem solving with FDG positron emission mammography. Clin Positron Imaging 2000 Jul; 3(4):149.

49. Chin R, Jr., McCain TW, Miller AA, Dunagan DP, Acostamadiedo J, Douglas Case L, Harkness BA, Adler LP, Haponik EF. Whole body FDG-PET for the evaluation and staging of small cell lung cancer: a preliminary study. Lung Cancer 2002 Jul; 37(1):1-6.

50. Siegel BA, Adler LP, Wahl RL. FDG positron emission tomography detection of pelvic nodal metastases in gynecologic cancer. Am J Roentgenol 2002 Mar; 178(3):762-763.

51. Davis PW, Perrier ND, Adler L, Levine EA. Incidental thyroid carcinoma identified by positron emission tomography scanning obtained for metastatic evaluation. Am Surg 2001 Jun; 67(6):582-584.

52. Adler LP, Weinberg IN, Bradbury MS, Levine E, Lesko NM, Geisinger K, Berg WA, Freimanis R. Method for combined FDG-PET and radiographic imaging of primary breast cancers. Breast J 2003; 9(3):163-166.

53. Israel-Mardirosian N, Adler LP. Positron emission tomography of soft tissue sarcomas. Curr Opin Oncol 2003; 15:327-330.

54. Levine, E.A., Freimanis, R.I., Perrier, N.D., Morton, K., Lesko, N.M., Bergman, S., Geisinger, K.R., Williams, R.C., Sharpe, C., Zavarzin, V., Weinberg, I.N., Stepanov, P.Y., Beylin, D., Lauckner, K., Doss, M., Lovelace, J., Adler, L.P. Positron emission mammography: initial clinical results. Ann Surg Oncol 2003; 10:86-91.

55. Parsons RB, Milestone BN, Adler LP. Radiographic assessment of airway tumors. Chest Surg Clin N Am 2003; 13:63-77.

56. Gonzlez Trotter DE, Doss M, Manjeshwar RM, Shaller C, Robinson MK, Tandon R, Adams GP, Adler LP. Quantitation of small-animal I-124 activity distributions using a clinical PET/CT Scanner. J. Nuclear Med. 2004; 45(7): 1237-1244.

57. Bagheri B, Maurer A, Cone L, Doss M, Adler L.P. Characterization of the normal adrenal gland with 18F-FDG PET/CT. J. Nuclear Med. 2004; 45(8): 1340-1343

58. Konski, A, Doss, M, Milestone, B, Haluszka, O, Hanlon, A., Adler, LP, Freedman, G. The integration of 18-Fluoro-deoxy-glucose Positron Emission Tomography (PET) and Endoscopic Ultrasound (EUS) in the Treatment Planning Process for Esophageal Carcinoma. Int J Rad Oncol Biol Phys 2005 Mar 15;61(4):1123-8.

59. Buyyounouski, MK, Klump, WJ, Konski, A, Wu, H, Adler, LP. FDG PET Imaging of signet-ring cell adenocarcinoma of the stomach. Clin Nucl Med. 2005 Feb; 30(2):118-9.

60. Robinson MK, Doss M, Shaller C, Narayanan D, Marks JD, Adler LP, Gonzalez Trotter DE, Adams GP.Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody. Cancer Res. 2005 Feb 15;65(4):1471-8.

61. Tafra L, Cheng Z, Uddo J, Lobrano MB, Stein W, Berg WA, Levine E, Weinberg IN, Narayanan D, Ross E, Beylin D, Yarnall S, Keen R, Sawyer K, Van Geffen J, Freimanis RL, Staab E, Adler LP, Lovelace J, Shen P, Stewart J, Dolinsky S., Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer Am J Surg. 2005 Oct;190(4):628-32.

62. Avril, N and Adler, LP, F-18 fluorodeoxyglucose Positron Emission Tomography Imaging for Primary Breast Cancer and Loco-Regional Staging, PET Clinics of North America 1 (2006) 1-13.

63. Berg WA, Weinberg IN, Narayanan D, Lobrano ME, Ross E, Amodei L, Tafra L, Adler LP, Uddo J, Stein W 3rd, Levine EA; Positron Emission Mammography Working Group. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. Breast J. 2006 Jul-Aug;12(4):309-23